BDBM590853 (R)-1-(4-fluorobenzyl)-N-(1- (4-fluorophenyl)ethyl)-6- (oxetan-3-yl)-2-oxo-1,2- dihydro-1,8-naphthyridine-3- carboxamide::US11564928, Compound 103

SMILES C[C@@H](NC(=O)c1cc2cc(cnc2n(Cc2ccc(F)cc2)c1=O)C1COC1)c1ccc(F)cc1

InChI Key InChIKey=IJQZYHAEMFBWLL-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590853   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590853(US11564928, Compound 103 | (R)-1-(4-fluorobenzyl)-...)
Affinity DataIC50: 3nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590853(US11564928, Compound 103 | (R)-1-(4-fluorobenzyl)-...)
Affinity DataIC50: 2.91E+3nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent